Senior insider sale
Chief Scientific Officer at CONTINEUM THERAPEUTICS, INC. — senior position signals high conviction
$783.9K
50.86K shares
What this filing means
LORRAIN DANIEL S. plans to sell 50.86K shares of CONTINEUM THERAPEUTICS, INC. valued at approximately $783.9K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 7/1/2026ACC: 0001950047-26-006723
Officer· Chief Scientific Officer
Since Mar 2026
50.86K
Shares to sell
$783.9K
Approx. market value
9.52K
Acquired (3 months)
1
Planned
4 completed
Securities Acquired — Last 3 Months2
Exercise of Stock Options
Cash
7/1/2026
5.35KRestricted Stock Units
N/A
5/9/2017
4.17KTotal acquired9.52K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
7/1/2026 | Exercise of Stock Options Cash | 5.35K | — |
5/9/2017 | Restricted Stock Units N/A | 4.17K | — |
| Total | 9.52K | ||
Planned & Completed Dispositions5
Completed
—Completed
Units to sell
28.83K
Market value
$462.3K
6/30/2026
—Completed
Units to sell
4.17K
Market value
$54.9K
6/1/2026
—Completed
Units to sell
4.17K
Market value
$54.7K
5/1/2026
—Completed
Units to sell
4.17K
Market value
$56.0K
4/6/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
9.52K
Market value
$156.0K
7/1/2026
Total
Units
50.86K
Value
$783.9K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
6/30/2026 | 28.83K | $462.3K | — | Completed |
6/1/2026 | 4.17K | $54.9K | — | Completed |
5/1/2026 | 4.17K | $54.7K | — | Completed |
4/6/2026 | 4.17K | $56.0K | — | Completed |
| Planned — Approximate Date | ||||
7/1/2026 | 9.52K | $156.0K | NASDAQ | Planned |
| Total | 50.86K | $783.9K | ||